Editorial Commentary:Improving and Enforcing Compounding Pharmacy Practices to Protect Patients-Reference-Cited by-同舟云学术

Editorial Commentary:Improving and Enforcing Compounding Pharmacy Practices to Protect Patients

Published:2006-10 Issue:7 Volume:43 Page:838-840
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Pegues David A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/43/7/838/1052799/43-7-838.pdf

Reference16 articles.

1. US Food and Drug Administration. Compliance policy guidance for Food and Drug Administration staff and industry. Section 460-200, pharmacy compounding. Available at: http://www.fda.gov/ora/compliance_ref/cpg/cpgdrg/cpg460-200.html. Accessed 22 June 2006.

2. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities—1995

3. Needed: Serious attention to sterile products

4. National survey of quality assurance activities for pharmacy-compounded sterile preparations

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extent and barriers to providing effective pharmaceutical compounding services in hospital and community pharmacies of a low-income country: Case of Southwest Ethiopia;The Journal of Medicine Access;2023-01

2. U.S. Compounding Pharmacy-Related Outbreaks, 2001–2013: Public Health and Patient Safety Lessons Learned;Journal of Patient Safety;2018-09

3. Laboratory replication of filtration procedures associated with Serratia marcescens bloodstream infections in patients receiving compounded amino acid solutions;American Journal of Health-System Pharmacy;2015-08-01

4. Compounded Ointment Results in Severe Toxicity in a Pediatric Patient;Pediatric Emergency Care;2013-11

5. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine;International Journal of Pharmacy Practice;2011-08-19